Biodexa Pharmaceuticals调整ADS比率:由1股ADS对应50股普通股改为对应400股,约2026年10月26日生效——SEC文件

美股速递
Oct 09

Biodexa Pharmaceuticals宣布变更ADS比率,由此前每1股ADS代表50股普通股,调整为每1股ADS代表400股普通股。该调整预计于2026年10月26日前后正式生效。上述信息来自SEC文件。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10